Psyence Biomedical Ltd. (PBM) Total Liabilities (2023 - 2026)
Psyence Biomedical (PBM) posted quarterly Total Liabilities of $623190.0 for Q1 2026, up 4.85% year-over-year from $594366.0 in Q1 2025, and down 33.92% quarter-over-quarter from $943068.0 in Q3 2025.
Psyence Biomedical Ltd. (PBM) Total Liabilities (2023 - 2026) Analysis & Trends
Psyence Biomedical's Total Liabilities history runs 4 years deep, the most recent figure standing at $623190.0 for Q1 2026.
- In Q1 2026, Total Liabilities rose 4.85% year-over-year to $623190.0; the TTM figure through Mar 2026 stood at $623190.0 (up 4.85% YoY), while the FY2026 annual figure was $623190.0, up 4.85% from the prior year.
- Total Liabilities for Q1 2026 stood at $623190.0, down from $943068.0 in the prior quarter.
- The five-year high for Total Liabilities was $12.1 million in Q1 2024, with the low at $28.75 in Q3 2023.
- The 4-year median for Total Liabilities is $943068.0 (2025), against an average of $2.8 million.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities surged 12203981.11% in 2024, then sank 95.09% in 2025.
- Psyence Biomedical's Total Liabilities stood at $28.75 in 2023, then soared by 12203981.11% to $3.5 million in 2024, then slumped by 73.12% to $943068.0 in 2025, then tumbled by 33.92% to $623190.0 in 2026.
- Business Quant data shows PBM's Total Liabilities at $623190.0 in Q1 2026, $943068.0 in Q3 2025, and $594366.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623,190.00 |
| Sep 30, 2025 | 943,068.00 |
| Mar 31, 2025 | 594,366.00 |
| Sep 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 12.10 Mn |
| Sep 30, 2023 | 28.75 |
| Mar 31, 2023 | 1.79 Mn |